Strategic Development of Complex Oral Therapies
By Rebecca Coutts
November 2, 2026
Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies
5 min read
False
Advertisement
Latest
What Will It Take to Control Continuous Biomanufacturing?
November 2, 2026
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
2 min read
Off-the-Shelf CAR T Shows Early Signal in Progressive Multiple Sclerosis
November 2, 2026
Phase I data show B-cell depletion and mostly stable or improved disability scores, but the uncontrolled study remains small and follow-up is limited
2 min read
The Challenge of Scaling Cell and Gene Therapy
By Mouj Hijazi
October 30, 2026
Erik Vaessen on the costs, complexities, and technologies shaping advanced therapy manufacturing.
5 min read
Staying the Course: Sitting Down With Mike Cooke
By Henry Thomas, James Strachan
October 29, 2026
AmacaThera Co-Founder and CEO Mike Cooke reflects on the long road from academic discovery to a potential new treatment for post-operative pain
9 min read
Prime Editing Creates Drug-Controllable T Cell Therapies
October 28, 2026
Engineered T cells resisted tacrolimus but remained sensitive to cyclosporin, providing a potential way to select or suppress them after administration
2 min read
Engineering a New Generation of Cancer-Fighting Cells
October 28, 2026
USC researchers develop a scalable cell engineering platform that could overcome key manufacturing and therapeutic limitations of CAR-based immunotherapies
2 min read
Video: Leading the Alpha Charge – with Øystein Soug
October 28, 2026
From the Norwegian Air Force to alpha-emitting radiopharmaceuticals, Øystein Soug has taken the unconventional route to biotech leadership
1 min read
Amgen Expands Veeva Partnership
October 27, 2026
Global deployment of Veeva Vault CRM aims to help Amgen uncover treatment barriers and accelerate the delivery of new therapies
2 min read
Is Stem Cell Therapy Quality Control Missing Proteotoxic Cargo?
October 26, 2026
Review calls for senescence screening and EV proteomic profiling to assess whether cell therapy products can maintain protein homeostasis after transplantation
2 min read
